Here’s another name to add to the list of life science-focused venture firms raising or closing funds over $100 million this year: Longitude Venture Partners.
The VC firm that specializes in medical device, biotechnology, diagnostics and R&D tools investment revealed in a U.S. Securities and Exchange Commission filing last week that it has raised more than $331 million for a second fund and could continue raising up to $375 million. A partner at the firm was not available to comment.
To read the full, original article click on this link: Longitude Venture Partners goes after a $375M second fund for life science investments | MedCity News
